D

Doxa AB
STO:DOXA

Watchlist Manager
Doxa AB
STO:DOXA
Watchlist
Price: 1.018 SEK 0.79% Market Closed
Market Cap: 1.3B SEK
Have any thoughts about
Doxa AB?
Write Note

Doxa AB
Note Receivable

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Doxa AB
Note Receivable Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Note Receivable CAGR 3Y CAGR 5Y CAGR 10Y
D
Doxa AB
STO:DOXA
Note Receivable
kr1.3B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
O
OssDsign AB
STO:OSSD
Note Receivable
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Xvivo Perfusion AB
STO:XVIVO
Note Receivable
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bactiguard Holding AB
STO:BACTI B
Note Receivable
kr2.9m
CAGR 3-Years
19%
CAGR 5-Years
43%
CAGR 10-Years
N/A
V
Vimian Group AB
STO:VIMIAN
Note Receivable
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
S
S2Medical AB (publ)
STO:S2M
Note Receivable
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Doxa AB
Glance View

Market Cap
1.3B SEK
Industry
Health Care

Doxa AB engages in the development, manufacture, and commercialization of bioceramic dental products. The company is headquartered in Uppsala, Uppsala. The company went IPO on 2014-04-07. The firm develops, manufactures and commercializes products based upon its technology platform of calcium aluminate hydrate and bioactive ceramics. Activities are divided into the therapy areas of orthopedics and odontology. Research areas within orthopedics are methods for treating fractures resulting from osteoporosis, reconstructive orthopedics and coating of implants. Research areas within odontology are tooth restoration and implant fixation.

DOXA Intrinsic Value
0.75 SEK
Overvaluation 26%
Intrinsic Value
Price
D

See Also

What is Doxa AB's Note Receivable?
Note Receivable
1.3B SEK

Based on the financial report for Jun 30, 2024, Doxa AB's Note Receivable amounts to 1.3B SEK.

What is Doxa AB's Note Receivable growth rate?
Note Receivable CAGR 1Y
295%

Over the last year, the Note Receivable growth was 295%.

Back to Top